Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK, Moderna and mRNA
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and respiratory syncytial virus shot mResvia.
GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA.
GSK sues Moderna over mRNA vaccine technology
GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's the latest in a series of legal fights over who owns the intellectual property behind mRNA technology and whether some companies are entitled to royalties on future sales.
Northwestern University Sues Moderna Over Spikevax Vaccine
Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the District of Delaware, alleging infringement of three patents the school says cover technology key to the delivery method for Moderna’s groundbreaking messenger-RNA (mRNA) COVID-19 vaccine.
British drugmaker sues Moderna for patent infringement related to mRNA vaccines
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent rights in its mRNA technology used to develop its COVID-19 and RSV vaccines.
GSK sues Moderna over Covid and RSV vaccines
GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax infringed up to seven patents covering lipid mRNA vaccine formulation technology. It is also suing Moderna for infringing the same mRNA technology through the sale of its recently approved RSV shot mResvia.
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit
London: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating GSK's patent rights in messenger RNA
Northwestern sues Moderna for alleged patent infringement in COVID shots
Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to combat the pandemic.
infectiousdiseaseadvisor.com
1d
Investigational RSV Vaccine mRNA-1345: Revaccination Safe in Eligible Older Adults
There were no safety concerns identified among older adults following revaccination with the investigational respiratory syncytial virus vaccine mRNA-1345, and immune responses elicited by ...
GlobalData on MSN
23h
mRNA licensing agreements surge 800% amid GSK lawsuits
It follows a similar lawsuit against Pfizer and BioNTech filed in April in which GSK alleges the companies were in violation ...
pharmaphorum
3d
GSK turns its guns on Moderna in mRNA jab patent dispute
The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...
devdiscourse
3d
Patent Wars: GSK Takes on Moderna Over mRNA Innovations
GlaxoSmithKline has filed lawsuits against Moderna in a Delaware federal court, alleging infringement of patents related to ...
scrippsnews on MSN
8d
Harnessing Your Health: What you need to know about COVID-19, flu, and RSV for the fall and winter
There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...
1d
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback